Report overview
Endometrial cancer is a cancer that arises from the endometrium (the lining of the uterus or womb). It is the result of the abnormal growth of cells that have the ability to invade or spread to Others parts of the body. The first sign is most often vaginal bleeding not associated with a menstrual period. Others symptoms include pain with urination, pain during sexual intercourse, or pelvic pain. Endometrial cancer occurs most commonly after menopause.
This report contains market size and forecasts of Endometrial Cancer in Global, including the following market information:
Global Endometrial Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Endometrial Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hysterectomy Techniques Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endometrial Cancer include Pfizer, Johnson & Johnson, Boston Scientific, GE, Karl Storz, Koninklijke Philips, Celgene, Lupin and LiNA Medical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endometrial Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometrial Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Type, 2021 (%)
Hysterectomy Techniques
Radiation
Hormone Therapy
ChemOthersapy
Global Endometrial Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Gynecology Centers
Others
Global Endometrial Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endometrial Cancer Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endometrial Cancer revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Endometrial Cancer revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Johnson & Johnson
Boston Scientific
GE
Karl Storz
Koninklijke Philips
Celgene
Lupin
LiNA Medical
Bayer AG
Cooper Surgical
Hologic
